Painreform Company Insiders
| PRFX Stock | USD 0.83 0.03 3.49% |
Painreform employs about 2 people. The company is managed by 9 executives with a total tenure of roughly 5 years, averaging almost 0.0 years of service per executive, having 0.22 employees per reported executive. Break down of Painreform's management performance can provide insight into the company performance.
Painreform | Build AI portfolio with Painreform Stock |
Painreform Management Team Effectiveness
The company has return on total asset (ROA) of (0.3619) % which means that it has lost $0.3619 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2765) %, meaning that it created substantial loss on money invested by shareholders. Painreform's management efficiency ratios could be used to measure how well Painreform manages its routine affairs as well as how well it operates its assets and liabilities.Painreform Workforce Comparison
Painreform is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 359. Painreform maintains roughly 2.0 in number of employees contributing less than 1% to equities under Health Care industry.
Painreform Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Painreform Price Series Summation is a cross summation of Painreform price series and its benchmark/peer.
Painreform Notable Stakeholders
A Painreform stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Painreform often face trade-offs trying to please all of them. Painreform's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Painreform's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Ilan MBA | CEO CFO | Profile | |
| Ehud Geller | Executive Chairman | Profile | |
| Sigal Aviel | Chief Officer | Profile | |
| Rita Keynan | Vice Operations | Profile | |
| Eyal Broder | Interim Officer | Profile | |
| MBA MBA | CEO CFO | Profile | |
| Pr Hazum | CTO Director | Profile | |
| Stephen DMD | Executive Development | Profile | |
| Sigal eMBA | Chief Officer | Profile |
About Painreform Management Performance
The success or failure of an entity such as Painreform often depends on how effective the management is. Painreform management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Painreform management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Painreform management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel. Painreform is traded on NASDAQ Exchange in the United States.
Please note, the imprecision that can be found in Painreform's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Painreform. Check Painreform's Beneish M Score to see the likelihood of Painreform's management manipulating its earnings.
Painreform Workforce Analysis
Traditionally, organizations such as Painreform use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Painreform within its industry.Painreform Manpower Efficiency
Return on Painreform Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 7.3M | |
| Net Loss Per Executive | 1.6M | |
| Working Capital Per Employee | 993K | |
| Working Capital Per Executive | 220.7K |
Additional Tools for Painreform Stock Analysis
When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.